Anticoagulation for Secondary Atrial Fibrillation

Suellen Li; Professor Gregory Lip; Darae Ko; Allan J. Walkey

doi:10.1056/nejmclde2311699

Related publications

Article2019

Sex Differences in Presentation, Quality of Life, and Treatment in Chinese Atrial Fibrillation Patients: Insights from the China Atrial Fibrillation Registry Study

Yanming Li, Chao Jiang, Liu He, Xinxu Li, Xiaoxia Hou, Sanshuai Chang, Professor Gregory Lip, Xin Du, Jianzeng Dong, Changsheng Ma

Article2022

Thromboembolic Risk in Patients With Pneumonia and New-Onset Atrial Fibrillation Not Receiving Anticoagulation Therapy

Mette Søgaard, Flemming Skjøth, Peter Brønnum Nielsen, Jesper Smit, Michael Dalager‐Pedersen, Torben Bjerregaard Larsen, Professor Gregory Lip

Article2016

Timing of anticoagulation therapy in patients with acute ischaemic stroke and atrial fibrillation

Maurizio Paciaroni, Giancarlo Agnelli, Walter Ageno, Valeria Caso

Article2020

Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation

Michela Giustozzi, Giancarlo Agnelli, Silvia Quattrocchi, Monica Acciarresi, Andrea Alberti, Valeria Caso, Maria Cristina Vedovati, Michele Venti, Maurizio Paciaroni

Article2019

Anticoagulation After Stroke in Patients With Atrial Fibrillation

Riccardo Altavilla, Valeria Caso, Fabio Bandini, Giancarlo Agnelli, Georgios Tsivgoulis, Shadi Yaghi, Karen L. Furie, Prasanna Tadi, Cecilia Becattini, Marialuisa Zedde, Azmil H. Abdul‐Rahim, Kennedy R. Lees, Andrea Alberti, Michele Venti, Monica Acciarresi, Cataldo D’Amore, Maria Giulia Mosconi, Ludovica Anna Cimini, Jessica Fusaro, Paolo Bovi, Monica Carletti, Alberto Rigatelli, Manuel Cappellari, Jukka Putaala,